%0 Journal Article %J Fam Pract %D 2013 %T Tackling transitions in patient care: the process of medication reconciliation %A Redmond, P %A Grimes, T %A McDonnell, R %A Boland, F %A Hughes, CM %A Fahey, T %K medication reconciliation %B Fam Pract %V 30 %P 483-4 %8 2013 Oct %@ http://fampra.oxfordjournals.org/content/30/5/483.extract %G eng %U http://fampra.oxfordjournals.org/content/30/5/483.extract %N 5 %R 10.1093/fampra/cmt051 %0 Journal Article %J Implementation Science %D 2016 %T Sustained effectiveness of a multifaceted intervention to reduce potentially inappropriate prescribing in older patients in primary care (OPTI-SCRIPT study) %A Clyne, B %A Smith, SM %A Hughes, CM %A Boland, F %A Cooper, J %A Fahey, T %A on behalf of the OPTI-SCRIPT study team %B Implementation Science %V 11 %P 1-8 %8 2016 %G eng %N 79 %R 10.1186/s13012-016-0442-2 %0 Journal Article %J Addiction %D 2015 %T Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study %A Cousins, G %A Boland, F %A Courtney, Brenda %A Barry, Joe %A Lyons, S %A Fahey, T %K All-cause mortality;cohort study;drug-related deaths;maintenance treatment;methadone;mortality;opioid;supervised consumption %X Aim To assess whether risk of death increases during periods of treatment transition, and investigate the impact of supervised methadone consumption on drug-related and all-cause mortality. Design National Irish cohort study. Setting Primary care. Participants A total of 6983 patients on a national methadone treatment register aged 16–65 years between 2004 and 2010. Measurement Drug-related (primary outcome) and all-cause (secondary outcome) mortality rates and rate ratios for periods on and off treatment; and the impact of regular supervised methadone consumption. Results Crude drug-related mortality rates were 0.24 per 100 person-years on treatment and 0.39 off treatment, adjusted mortality rate ratio 1.63 [95% confidence interval (CI) = 0.66–4.00]. Crude all-cause mortality rate per 100 person-years was 0.51 on treatment versus 1.57 off treatment, adjusted mortality rate ratio 3.64 (95% CI = 2.11–6.30). All-cause mortality off treatment was 6.36 (95% CI = 2.84–14.22) times higher in the first 2 weeks, 9.12 (95% CI = 3.17–26.28) times higher in weeks 3–4, compared with being 5 weeks or more in treatment. All-cause mortality was lower in those with regular supervision (crude mortality rate 0.60 versus 0.81 per 100 person-years) although, after adjustment, insufficient evidence exists to suggest that regular supervision is protective (mortality rate ratio = 1.23, 95% CI = 0.67–2.27). Conclusions Among primary care patients undergoing methadone treatment, continuing in methadone treatment is associated with a reduced risk of death. Patients' risk of all-cause mortality increases following treatment cessation, and is highest in the initial 4-week period. %B Addiction %V 111 %8 09/2015 %G eng %U http://onlinelibrary.wiley.com/doi/10.1111/add.13087/full %N 1 %& 73-82 %R 10.1111/add.13087 %0 Journal Article %J BMC Pediatrics %D 2015 %T Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study %A Boland, F %A Galvin, R %A Reulbach, U %A Motterlini, N %A Kelly, D %A Bennett, K %A Fahey, T %K ADHD %K children %K pharmacoepidemiology %K Psychostimulant treatment %X Background: Psychotropic paediatric prescribing trends are increasing internationally. The aim of this study is to examine the prevalence and secular trends in psychotropic prescribing in Irish children and adolescents between 2002 and 2011. Methods: Data was obtained from the Irish General Medical Services (GMS) scheme pharmacy claims database from the Health Service Executive Primary Care Reimbursement Services (HSE-PCRS). Prescribing rates per 1000 eligible population and associated 95 % confidence intervals (CIs) were calculated across years (2002–2011), age groups (0–4, 5–11, 12–15 years) and gender. Rates of concomitant prescriptions for psycholeptics and antidepressants were also examined. The total expenditure costs were calculated and expressed as a percentage of the cost of all prescriptions for this age group (≤15 years). Results: In 2002, 3.77/1000 GMS population (95 % CI: 3.53–4.01) received at least one psychostimulant prescription and this rate increased to 8.63/1000 GMS population (95 % CI: 8.34–8.92) in 2011. Methylphenidate was the most frequently prescribed psychostimulant. For both males and females the prevalence of medication use was highest among the 12–15 year old group. On average, a psycholeptic medication was prescribed to 8 % of all psychostimulant users and an antidepressant was concomitantly prescribed on average to 2 %. Total expenditure rose from €89,254 in 2002 to €1,532,016 in 2011. Conclusions: The rate and cost of psychostimulant prescribing among GMS children and adolescents in Ireland increased significantly between 2002 and 2011. Further research is necessary to assess the safety, efficacy and economic impact of concomitant psychotropic prescribing in this population. %B BMC Pediatrics %V 15 %8 09/2015 %G eng %U http://www.biomedcentral.com/1471-2431/15/118 %N 118 %R DOI 10.1186/s12887-015-0435-3 %0 Journal Article %J HRB Open Research %D 2021 %T Protocol for a mixed methods process evaluation of the LinkMM randomised controlled trial “Use of link workers to provide social prescribing and health and social care coordination for people with complex multimorbidity in socially deprived areas” [versio %A Kiely, B %A O'Donnell, P %A Byers, V %A Galvin, E %A Boland, F %A Smith, SM %A Connolly, D %A O'Shea, E %A Clyne, B %B HRB Open Research %V 4:38 %8 04/2021 %G eng %R https://doi.org/10.12688/hrbopenres.13258.1 %0 Journal Article %J Journal of Multimorbidity and Comorbidity %D 2021 %T Primary care-based link workers providing social prescribing to improve health and social care outcomes for people with multimorbidity in socially deprived areas (the LinkMM trial): Pilot study for a pragmatic randomised controlled trial %A Kiely, B %A Connolly, D %A Clyne, B %A Boland, F %A O'Donnell, P %A O'Shea, E %A Smith, SM %B Journal of Multimorbidity and Comorbidity %V 11 %8 05/2021 %G eng %R https://doi.org/10.1177/26335565211017781 %0 Journal Article %J BMJ Open %D 2020 %T Prevalence and predictors of oral to intravenous antibiotic switch among adult emergency department patients with acute bacterial skin and skin structure infection: a pilot, prospective cohort study %A Quirke, M %A Mitchell, N %A Varley, J %A Kelly, S %A Boland, F %A Moughty, A %A McKeever, J %A Fahey, T %A Wakai, A %B BMJ Open %V 10 %8 08/2020 %G eng %N 8 %R 10.1136/bmjopen-2019-034057 %0 Journal Article %J BMJ Open %D 2015 %T Prevalence and predictors of initial oral antibiotic treatment failure in adult emergency department patients with cellulitis: a pilot study %A Quirke, M %A Boland, F %A Fahey, T %A O'Sullivan, R %A Hill, A %X Introduction Assessment of cellulitis severity in the emergency department (ED) setting is problematic. Given the lack of research performed to describe the epidemiology and management of cellulitis, it is unsurprising that heterogeneous antibiotic prescribing and poor adherence to guidelines is common. It has been shown that up to 20.5% of ED patients with cellulitis require either a change in route or dose of the initially prescribed antibiotic regimen. The current treatment failure rate for empirically prescribed oral antibiotic therapy in Irish EDs is unknown. The association of patient risk factors with treatment failure has not been described in our setting. Lower prevalence of community-acquired methicillin-resistant Staphylococcus aureus-associated infection, differing antibiotic prescribing preferences and varying availability of outpatient intravenous therapy programmes may result in different rates of empiric antibiotic treatment failure from those previously described. %B BMJ Open %V 5 %G eng %U http://bmjopen.bmj.com/content/5/6/e008150.full?sid=0db5be06-30df-4230-8fa4-2449ec3e3ce6 %N 6 %R 2015;5:e008150 doi:10.1136/bmjopen-2015-008150 %0 Journal Article %J BMC Complementary & Alternative Medicine %D 2013 %T Prescribing patterns of glucosamine in an older population: a national cohort study %A Galvin, R %A Cousins, G %A Boland, F %A Motterlini, N %A Bennett, K %A Fahey, T %K Cost-effectiveness %K Glucosamine %K Osteoarthritis %X Background: Glucosamine is commonly prescribed as a disease modulating agent in osteoarthritis. However, the evidence to date suggests that it has a limited impact on the clinical symptoms of the disease including joint pain, radiological progression, function and quality of life. The aim of this study was to examine the prescribing patterns of glucosamine from 2002–2011 in an elderly Irish national population cohort using data from the Health Service Executive Primary Care Reimbursement (HSE-PCRS) General medical services (GMS) Scheme. Methods: Patients aged ≥ 70 years on the HSE-PCRS pharmacy claims database between January 2002 and December 2011 were included. ATC code M01AX05 (glucosamine) was extracted. Prevalence rates per 1000 eligible population with 95% confidence intervals were calculated for all years and age groups (70–74 years, ≥75 years). A negative binomial regression analysis was used to determine longitudinal usage trends and compare prevalence rates across years, sex and age groups. Results: The annual patient rate of glucosamine prescribing increased significantly from 13.0/1000 eligible population (95% CI 12.6-13.4) in 2002 to 68.7/1000 population (95% CI 67.8-69.5) in 2009 before decreasing to 62.4/1000 population (95% CI 61.6-63.2) in 2011. The rate of prescribing of glucosamine varied with sex, with women receiving significantly more prescriptions than men. The cost of glucosamine also increased from 2002–2008. In 2008 total expenditure reached a high of €4.6 million before decreasing to €2.6 million in 2011. Conclusion: The national trend in prescribing of glucosamine increased significantly from 2002 to 2009 before decreasing in 2010 and 2011, in keeping with current international guidelines. There is a need for awareness among healthcare professionals and patients alike of the best available evidence to inform decision making relating to theprescription and consumption of such supplements. %B BMC Complementary & Alternative Medicine %V 13 %8 11/2013 %G eng %U http://www.biomedcentral.com/content/pdf/1472-6882-13-316.pdf %9 Published Article Journal %& 316 %R 10.1186/1472-6882-13-316 %0 Journal Article %J HRB Open Research %D 2021 %T Overuse and underuse of cardiovascular diagnostic and therapeutic procedures for community-dwelling adults: a protocol for a systematic review [version 1; peer review: 2 approved] %A Quinn, D %A Byrne, D %A Fahey, T %A Kenny, RA %A McGarrigle, C %A Wallace, E %A Boland, F %B HRB Open Research %V 4:99 %8 04/2021 %G eng %R https://doi.org/10.12688/hrbopenres.13330.1 %0 Journal Article %J BMC Family Practice %D 2015 %T OPTIMAL, an occupational therapy led self-management support programme for people with multimorbidity in primary care: a randomized controlled trial %A Garvey, J %A Connolly, D %A Boland, F %A Smith, SM %K multimorbidity %K Occupational therapy %K Randomised controlled trial %K Self-management %X Background We investigated the effectiveness of an occupational therapy led self-management support programme, OPTIMAL, designed to address the challenges of living with multiple chronic conditions or multimorbidity in a primary care setting. Methods Pragmatic feasibility randomised controlled trial including fifty participants with multimorbidity recruited from family practice and primary care settings. OPTIMAL is a six-week community-based programme, led by occupational therapy facilitators and focuses on problems associated with managing multimorbidity. The primary outcome was frequency of activity participation. Secondary outcomes included self-perception of, satisfaction with and ability to perform daily activities, independence in activities of daily living, anxiety and depression, self-efficacy, health-related quality of life, self-management support, healthcare utilisation and individualised goal attainment. Outcomes were collected within two weeks of intervention completion. Results There was a significant improvement in frequency of activity participation, measured using the Frenchay Activities Index, for the intervention group compared to the control group (Adjusted Mean Difference at follow up 4.22. 95% Confidence Interval 1.59-6.85). There were also significant improvements in perceptions of activity performance and satisfaction, self-efficacy, independence in daily activities and quality of life. Additionally, the intervention group demonstrated significantly higher levels of goal achievement, following the intervention. No significant differences were found between the two groups in anxiety, depression, self-management scores or healthcare utilisation. Conclusions OPTIMAL significantly improved frequency of activity participation, self-efficacy and quality of life for patients with multimorbidity. Further work is required to test the sustainability of these effects over time but this study indicates that it is a promising intervention that can be delivered in primary care and community settings. Trial registration Trial Number: ISRCTN67235963 %B BMC Family Practice %V 16 %8 05/2015 %G eng %U http://www.biomedcentral.com/1471-2296/16/59/abstract %N 59 %R doi:10.1186/s12875-015-0267-0 %0 Journal Article %J BMJ Open %D 2021 %T Novel approach to meta-analysis of tests and clinical prediction rules with three or more risk categories %A Ebell, MH %A Walsh, M %A Boland, F %A McKay, B %A Fahey, T %B BMJ Open %V 11 %8 02/2021 %G eng %N 2 %R http://dx.doi.org/10.1136/bmjopen-2019-036262 %0 Journal Article %J BMJ Open %D 2021 %T Link workers providing social prescribing and health and social care coordination for people with multimorbidity in socially deprived areas (the LinkMM trial): protocol for a pragmatic randomised controlled trial %A Kiely, B %A Clyne, B %A Boland, F %A O'Donnell, P %A Connolly, D %A O'Shea, E %A Smith, SM %B BMJ Open %V 11 %8 02/2021 %G eng %R doi:10.1136/bmjopen-2020-041809 %0 Journal Article %J The Cochrane Collaboration %D 2013 %T Interventions for improving medication reconciliation across transitions of care (Protocol) %A Redmond, P %A Grimes, T %A McDonnell, R %A Boland, F %A Hughes, CM %A Fahey, T %X This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effect of medication reconciliation on medication discrepancies, patient related outcomes and healthcare utilisation in patients receiving this intervention during transitions of care compared to patients not receiving medication reconciliation. %B The Cochrane Collaboration %I John Wiley & Sons, Ltd %G eng %R 10.1002/14651858.CD010791 %0 Journal Article %J BMJ Open %D 2021 %T Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial %A Croke, A %A Moriarty, F %A Boland, F %A McCullagh, L %A Cardwell, K %A Smith, SM %A Clyne, B %B BMJ Open %V 11 %8 03/2021 %G eng %R http://dx.doi.org/10.1136/bmjopen-2020-041541 %0 Journal Article %J Family Practice %D 2016 %T GPs’ and community pharmacists’ opinions on medication management at transitions of care in Ireland %A Redmond, P %A Carroll, H %A Grimes, T %A Galvin, R %A McDonnell, R %A Boland, F %A McDowell, R %A Hughes, CM %A Fahey, T %X Objective. The aim of this study was to survey GPs and community pharmacists (CPs) in Ireland regarding current practices of medication management, specifically medication reconciliation, communication between health care providers and medication errors as patients transition in care.Methods. A national cross-sectional survey was distributed electronically to 2364 GPs, 311 GP Registrars and 2382 CPs. Multivariable associations comparing GPs to CPs were generated and content analysis of free text responses was undertaken.Results. There was an overall response rate of 17.7% (897 respondents—554 GPs/Registrars and 343 CPs). More than 90% of GPs and CPs were positive about the effects of medication reconciliation on medication safety and adherence. Sixty per cent of GPs reported having no formal system of medication reconciliation. Communication between GPs and CPs was identified as good/very good by >90% of GPs and CPs. The majority (>80%) of both groups could clearly recall prescribing errors, following a transition of care, they had witnessed in the previous 6 months. Free text content analysis corroborated the positive relationship between GPs and CPs, a frustration with secondary care communication, with many examples given of prescribing errors.Conclusions. While there is enthusiasm for the benefits of medication reconciliation there are limited formal structures in primary care to support it. Challenges in relation to systems that support inter-professional communication and reduce medication errors are features of the primary/secondary care transition. There is a need for an improved medication management system. Future research should focus on the identified barriers in implementing medication reconciliation and systems that can improve it. %B Family Practice %V 33 %P 172-178 %G eng %U http://fampra.oxfordjournals.org/content/33/2/172.abstract %R 10.1093/fampra/cmw006 %0 Journal Article %J 11 %D 2021 %T Geographical variation of emergency hospital admissions for ambulatory care sensitive conditions in older adults in Ireland 2012–2016 %A Walsh, ME %A Cronin, S %A Boland, F %A Ebell, MH %A Fahey, T %A Wallace, E %B 11 %8 01/2021 %G eng %R https://doi.org/10.1136/ bmjopen-2020-042779 %0 Journal Article %J Annals of Family Medicine %D 2015 %T Effectiveness of a Multifaceted Intervention for Potentially Inappropriate Prescribing in Older Patients in Primary Care: A Cluster-Randomized Controlled Trial (OPTI-SCRIPT Study) %A Clyne, B %A Smith, SM %A Hughes, CM %A Boland, F %A Bradley, MC %A Cooper, J %A Fahey, T %A on behalf of the OPTI-SCRIPT study team %B Annals of Family Medicine %V 13 %P 545 - 553 %8 11/2015 %G eng %U http://www.annfammed.org/content/13/6/545.abstractN2 - PURPOSE Potentially inappropriate prescribing (PIP) is common in older people and can result in increased morbidity, adverse drug events, and hospitalizations. The OPTI-SCRIPT study (Optimizing Prescr %N 6 %! The Annals of Family Medicine %R 10.1370/afm.1838. %0 Journal Article %J British Journal of General Practice %D 2021 %T Effect of the OPTIMAL programme on self-management of multimorbidity in primary care: a randomised controlled trial %A O'Toole, L %A Connolly, D %A Boland, F %A Smith, SM %B British Journal of General Practice %V 71 %8 03/2021 %G eng %N 705 %& 303 %R https://doi.org/10.3399/bjgp20x714185 %0 Journal Article %J BMJ Open %D 2022 %T Effect of social prescribing link workers on health outcomes and costs for adults in primary care and community settings: a systematic review %A Kiely, B %A Croke, A %A O'Shea, M %A Boland, F %A O'Shea, E %A Connolly, D %A Smith, SM %B BMJ Open %V 12:e062951 %8 10/2022 %G eng %R doi: 10.1136/bmjopen-2022-062951 %0 Journal Article %J BMC Cancer %D 2014 %T Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study %A Galvin, R %A Joyce, D %A Downey, E %A Boland, F %A Fahey, T %A Hill, A %K Breast cancer %K Diagnosis %K primary care %X Abstract BACKGROUND: The number of primary care referrals of women with breast symptoms to symptomatic breast units (SBUs) has increased exponentially in the past decade in Ireland. The aim of this study is to develop and validate a clinical prediction rule (CPR) to identify women with breast cancer so that a more evidence based approach to referral from primary care to these SBUs can be developed. METHODS: We analysed routine data from a prospective cohort of consecutive women reviewed at a SBU with breast symptoms. The dataset was split into a derivation and validation cohort. Regression analysis was used to derive a CPR from the patient's history and clinical findings. Validation of the CPR consisted of estimating the number of breast cancers predicted to occur compared with the actual number of observed breast cancers across deciles of risk. RESULTS: A total of 6,590 patients were included in the derivation study and 4.9% were diagnosed with breast cancer. Independent clinical predictors for breast cancer were: increasing age by year (adjusted odds ratio 1.08, 95% CI 1.07-1.09); presence of a lump (5.63, 95% CI 4.2-7.56); nipple change (2.77, 95% CI 1.68-4.58) and nipple discharge (2.09, 95% CI 1.1-3.97). Validation of the rule (n = 911) demonstrated that the probability of breast cancer was higher with an increasing number of these independent variables. The Hosmer-Lemeshow goodness of fit showed no overall significant difference between the expected and the observed numbers of breast cancer (χ(2)HL: 6.74, p-value: 0.56). CONCLUSIONS: This study derived and validated a CPR for breast cancer in women attending an Irish national SBU. We found that increasing age, presence of a lump, nipple discharge and nipple change are all associated with increased risk of breast cancer. Further validation of the rule is necessary as well as an assessment of its impact on referral practice. %B BMC Cancer %V 14 %G eng %U http://www.ncbi.nlm.nih.gov/pubmed/25277332 %N 743 %R 10.1186/1471-2407-14-743 %0 Journal Article %J BMJ Open 2015 %D 2015 %T Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland %A O Sullivan, K %A Reulbach, U %A Boland, F %A Moschetti, I %A Kelly, D %A Bennett, K %A Fahey, T %X Objective To examine the prevalence and secular trends in benzodiazepine (BZD) prescribing in the Irish paediatric population. In addition, we examine coprescribing of antiepileptic, antipsychotic, antidepressant and psychostimulants in children receiving BZD drugs and compare BZD prescribing in Ireland to that in other European countries. Setting Data were obtained from the Irish General Medical Services (GMS) scheme pharmacy claims database from the Health Service Executive (HSE)—Primary Care Reimbursement Services (PCRS). Participants Children aged 0–15 years, on the HSE-PCRS database between January 2002 and December 2011, were included. Primary and secondary outcome measures Prescribing rates were reported over time (2002–2011) and duration (≤ or >90 days). Age (0–4, 5–11, 12–15) and gender trends were established. Rates of concomitant prescriptions for antiepileptic, antipsychotics, antidepressants and psychostimulants were reported. European prescribing data were retrieved from the literature. Results Rates decreased from 2002 (8.56/1000 GMS population: 95% CI 8.20 to 8.92) to 2011 (5.33/1000 GMS population: 95% CI 5.10 to 5.55). Of those children currently receiving a BZD prescription, 6% were prescribed BZD for >90 days. Rates were higher for boys in the 0–4 and 5–11 age ranges, whereas for girls they were higher in the 12–15 age groups. A substantial proportion of children receiving BZD drugs are also prescribed antiepileptic (27%), antidepressant (11%), antipsychotic (5%) and psychostimulant (2%) medicines. Prescribing rates follow a similar pattern to that in other European countries. Conclusions While BZD prescribing trends have decreased in recent years, this study shows that a significant proportion of the GMS children population are being prescribed BZD in the long term. This study highlights the need for guidelines for BZD prescribing in children in terms of clinical indication and responsibility, coprescribing, dosage and duration of treatment. %B BMJ Open 2015 %V 5 %G eng %U http://bmjopen.bmj.com/content/5/6/e007070.long %N 6 %R 2015;5:e007070 doi:10.1136/bmjopen-2014-007070 %0 Journal Article %J BMC Pediatrics %D 2015 %T Antidepressant prescribing in Irish children:secular trends and international comparison in the context of a safety warning %A O’Sullivan, K %A Boland, F %A Reulbach, U %A Motterlini, N %A Kelly, D %A Bennett, K %A Fahey, T %K Anti-depressants %K children %K Paediatric prescribing %K Safety warning %X Background: In 2003, the Irish Medicines Board (IMB) warned against the treatment of childhood depression with selective serotonin reuptake inhibitors (SSRIs) due to increased risk of suicide. This study examined the effect of this warning on the prevalence of anti-depressants in Irish children and compared age and gender trends and international comparisons of prescription rates. Methods: A retrospective cohort study of the Irish Health Service Executive (HSE) pharmacy claims database for the General Medical Services (GMS) scheme for dispensed medication. Data were obtained for 2002–2011 for those aged ≤15 years. Prevalence of anti-depressants per 1000 eligible population, along with 95 % confidence intervals, were calculated. A negative binomial regression analysis was used to investigate trends and compare rates across years, sex and age groups (0–4, 5–11, 12–15 years). International prescribing data were retrieved from the literature. Results: The prevalence of anti-depressants decreased from 4.74/1000 population (95 % CI: 4.47-5.01) in 2002 to 2.61/1000 population (95 % CI: 2.43-2.80) in 2008. SSRI rates decreased from 2002 to 2008. Prescription rates for contra-indicated SSRIs paroxetine, sertraline and citralopram decreased significantly from 2002 to 2005, and, apart from paroxetine, only small fluctuations were seen from 2005 onwards. Fluoxetine was the most frequently prescribed anti-depressant and rates increased between 2002 and 2011. Anti-depressant rates were higher for younger boys and older girls. The Irish prevalence was lower than the US, similar to the U.K. and higher than Germany and Denmark. Conclusions: The direction and timing of these trends suggest that medical practitioners followed the IMB advice. %B BMC Pediatrics %V 15 %G eng %U http://www.biomedcentral.com/content/pdf/s12887-015-0436-2.pdf %N 119 %R DOI 10.1186/s12887-015-0436-2 %0 Generic %D 2014 %T Prevalence of Medication Use in Pregnancy Using the Irish Primary Care Research Network Database. RCSI Research Day 20th March 2014 %A Roche, A %A Walsh, DR %A Cronin, K %A Schelten, R %A McDonnell, R %A O'Brien, K %A Boland, F %A Swift-Donnelly, Erica %A Smith, SM %A Fahey, T %G eng %0 Generic %D 2014 %T Medication Reconciliation - Unintentional discontinuation of long term medication post hospitalisation NAPCRG New York 21-24 Nov 2014 %A Redmond, P %A Grimes, T %A McDonnell, R %A Boland, F %A Hughes, CM %A Fahey, T %G eng %0 Generic %D 2014 %T The Impact of OPTIMAL, an Occupation-Based Self-Management Programme, on Occupational Participation for Individuals with Multimorbidity: A Randomised Controlled Trial AUDGPI Cork 6-7 March 2014 %A Garvey, J %A Connolly, D %A Boland, F %A Smith, SM %X Background Multimorbidity, defined as the co-existence of two or more long-term conditions, presents a multitude of challenges to both the individual and healthcare services. There is a need to develop interventions to improve outcomes for individuals with multimorbidity (Smith SM et al. Cochrane review, 2012) and exploratory work indicated that an occupational therapy intervention may be effective (O’Toole, Connolly & Smith, 2013). Objectives The objective of this study was to evaluate the effectiveness of an occupation-based self-management programme (OPTIMAL) in a sample of adults with multimorbidity. Methods This research was guided by the Medical Research Council Framework for the development and evaluation of complex interventions (MRC, 2008). This current study was an exploratory RCT in the preliminary stages of Phase III. The Consolidated Standards of Reporting Trials (CONSORT) guidelines were used to guide the research. Participants were recruited from primary care team members, primarily GPs, in the South Inner City Dublin region. Eligibility criteria included age over eighteen years, a minimum of two chronic conditions and a minimum of four repeat medications. %G eng %U http://hrbcentreprimarycare.ie/ppt/MSc SM MM Poster AUDGPI 2014 Final Version.pdf %0 Generic %D 2015 %T Cross-sectional survey of general practitioners’ and community pharmacists’ opinions on medication management at transitions of care in Ireland. RCSI Research Day. March 2015 %A Carroll, H %A Redmond, P %A Grimes, T %A Galvin, R %A McDonnell, R %A Boland, F %A Hughes, CM %A Fahey, T %G eng %0 Generic %D 2014 %T Addressing potentially inappropriate prescribing in primary care: results from the OPTI-SCRIPT cluster randomised controlled trial. IGS October 2014 %A Clyne, B %A Smith, SM %A Hughes, CM %A Bradley, MC %A Boland, F %A Fahey, T %G eng %0 Generic %D 2014 %T Addressing potentially inappropriate prescribing in primary care: results from the OPTI-SCRIPT cluster randomised controlled trial. AUDGPI Cork 6-7March 2014 %A Clyne, B %A Smith, SM %A Hughes, CM %A Bradley, MC %A Boland, F %A Fahey, T %G eng %U http://hrbcentreprimarycare.ie/ppt/AUDGPI_14 Final.pdf %0 Generic %D 2016 %T Unintentional discontinuation of long term medication post hospitalisation. AUDGPI 10th March 2016 %A Redmond, P %A McDonnell, R %A Grimes, T %A Boland, F %A Zarabzadeh, A %A Hughes, CM %A Fahey, T %G eng %0 Generic %D 2013 %T Quality of Prescribing Indicators for Children in Primary Care. SAPC ASM, University of Nottingham, 3 – 5 July 2013, Nottingham, UK %A O'Brien, K %A Cooper, J %A Boland, F %A Cummins, Anthony %A Redmond, P %A Smith, SM %A Hughes, CM %A Fahey, T %G eng %0 Generic %D 2013 %T Psychotropic medication in Irish children; trends and areas of inappropriate prescribing. AUDGPI Annual Scientific Meeting 2013, University of Limerick, 8 March 2013. Limerick %A Reulbach, U %A Boland, F %A Fahey, T %G eng %U http://www.hrbcentreprimarycare.ie/ppt/Udo Reulbach AUDGPI 2013.pdf %0 Generic %D 2021 %T Primary care-based link workers providing social prescribing to improve health and social care outcomes for people with multimorbidity in socially deprived areas (Link MM Trial). Oral presentation at Annual AUDGPI and ICGP (Virtual) Conference. March 2021 %A Kiely, B %A Galvin, E %A Byers, V %A Clyne, B %A Boland, F %A Connolly, D %A O'Shea, E %A Smith, SM %G eng %0 Generic %D 2013 %T Prescribing patterns of glucosamine in an elderly population: A national cohort study. AUDGPI Annual Scientific Meeting 2013, University of Limerick, 8 March 2013. Limerick %A Galvin, R %A Cousins, G %A Boland, F %A Motterlini, N %A Bennett, K %A Fahey, T %G eng %0 Generic %D 2022 %T One year follow up survey of participants in the LinkMM trial: Link worker engagement and community resource use. AUDGPI AGM March 2022 %A Kiely, B %A Loomba, S %A Boland, F %A Byers, V %A Galvin, E %A Clyne, B %A Connolly, D %A O'Shea, E %A Smith, SM %G eng %0 Generic %D 2022 %T Multidimensional relationships between medication beliefs and adherence to medications among older adults living with multimorbidity. 36th Annual Conference of the European Health Psychology Society. Bratislava, August 2022 %A Foley, L %A Doherty, AS %A Wallace, E %A Boland, F %A Hynes, L %A Murphy, AW %A Molloy, GJ %G eng %0 Generic %D 2015 %T Medication Reconciliation Cohort Study – The potentially unintentional discontinuation of long term medication post hospitalisation. WONCA October 2015, Istanbul %A Redmond, P %A Grimes, T %A McDonnell, R %A Boland, F %A Hughes, CM %A Fahey, T %G eng %0 Generic %D 2015 %T Interventions for improving medication reconciliation across transitions of care – systematic review. Oral Presentation. SAPC, Oxford, UK %A Redmond, P %A Grimes, T %A McDonnell, R %A Boland, F %A Hughes, CM %A Fahey, T %G eng %0 Generic %D 2021 %T Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial. Oral presentation at Annual Joint Scientific Meeting of the AUDGPI and ICGP (Virtual) Conference. March 2021 %A Croke, A %A Moriarty, F %A Boland, F %A McCullagh, L %A Cardwell, K %A Smith, SM %A Clyne, B %G eng %0 Generic %D 2016 %T Is hospitalisation associated with the unintentional discontinuation of appropriate long-term medication in the GP record? SAPC 6th -8th of July 2016 Dublin Castle/RCSI. %A Redmond, P %A McDowell, R %A Grimes, T %A Boland, F %A Zarabzadeh, A %A McDonnell, R %A Hughes, CM %A Fahey, T %G eng %0 Generic %D 2015 %T Effectiveness of a quality improvement intervention on potentially inappropriate prescribing in older patients in primary care: a cluster randomised controlled trial (the OPTI-SCRIPT study)(NAPCRG winner B Clyne from 2014) SAPC Oxford July 2015 %A Clyne, B %A Smith, SM %A Hughes, CM %A Boland, F %A Bradley, MC %A Cooper, J %A Fahey, T %G eng %0 Generic %D 2014 %T Effectiveness of a multifaceted intervention on potentially inappropriate prescribing in older patients in primary care: a cluster randomised controlled trial (the OPTI-SCRIPT study) NAPCRG New York 21-24 Nov 2014 %A Clyne, B %A Smith, SM %A Hughes, CM %A Boland, F %A Bradley, MC %A Cooper, J %A Fahey, T %G eng %0 Generic %D 2014 %T Effectiveness of a multifaceted intervention on potentially inappropriate prescribing in older patients in primary care: a cluster randomised controlled trial (the OPTI-SCRIPT study). SAPC July 9-11 2014 Edinburgh %A Clyne, B %A Smith, SM %A Hughes, CM %A Boland, F %A Bradley, MC %A Cooper, J %A Fahey, T %G eng %0 Generic %D 2022 %T Effect of social prescribing link workers on health outcomes and costs for adults in primary care and community settings: a systematic review. SAPC ASM, University of Central Lancashire, July 2022 %A Kiely, B %A Croke, A %A O'Shea, M %A Boland, F %A Connolly, D %A O'Shea, E %A Smith, SM %G eng %0 Generic %D 2014 %T Development and validation of a clinical prediction rule to identify women with suspected breast cancer: a prospective cohort study AUDGPI Cork 6-7 March 2014 %A Galvin, R %A Joyce, D %A Downey, E %A Boland, F %A Fahey, T %A Hill, A %G eng %0 Generic %D 2014 %T Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study SAPC July 9-11 2014 Edinburgh %A Galvin, R %A Joyce, D %A Downey, E %A Boland, F %A Fahey, T %A Hill, A %X The problem The number of primary care referrals of women with breast symptoms to symptomatic breast units (SBU) has increased yet the number of new cases with breast cancer has remained the same. The aim of this study is to develop and validate a clinical prediction rule (CPR) to identify women with breast cancer using routine data from an Irish national SBU so that a more evidence based approach to referral can be developed. The approach We analysed routine data from a prospective cohort of consecutive women reviewed at a SBU with breast symptoms. The dataset was split into a derivation and validation cohort. Regression analysis was used to derive a CPR from the patient’s history and clinical findings. Validation of the CPR consisted of estimating the number of breast cancers predicted to occur compared with the actual number of observed breast cancers across deciles of risk. Findings A total of 6,590 patients were included in the derivation study and 4.9% were diagnosed with breast cancer. Independent clinical predictors for breast cancer were: increasing age by year (adjusted odds ratio 1.08, 95%CI 1.07-1.09); presence of a lump (5.63, 95%CI 4.2-7.56); nipple change (2.77, 95%CI 1.68-4.58) and nipple discharge (2.09, 95% CI 1.1-3.97). Validation of the rule (n=911) demonstrated that the probability of breast cancer was higher with an increasing number of these independent variables. The Hosmer-Lemeshow goodness of fit showed no overall significant difference between the expected and the observed numbers of breast cancer (χ2HL: 6.74, p-value: 0.5647). Consequences This study derived and validated a CPR for breast cancer in women attending an Irish national SBU. We found that increasing age, presence of a lump, nipple discharge and nipple change are all associated with increased risk of breast cancer. Further validation of the rule is necessary as well as an assessment of its impact on referral practice. %G eng %0 Generic %D 2014 %T Benzodiazpine prescribing in Irish children. SAPC July 9-11 2014 Edinburgh %A O Sullivan, K %A Reulbach, U %A Boland, F %A Kelly, D %A Bennett, K %A Fahey, T %G eng %0 Generic %D 2016 %T OptiMaL: A primary care- based intervention for people with multimorbidity. COTEC-ENOTHE NUI Galway, 15th -19th of June 2016. %A Connolly, D %A Garvey, J %A O’Toole, L %A Boland, F %A Smith, SM %G eng